Alpha Tau Medical (DRTS) Earnings Date & Reports

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

DRTS is expected to report earnings to rise 4.45% to -11 cents per share on August 21

Alpha Tau Medical DRTS Stock Earnings Reports

Q2'25

Est.

$-0.11

Q1'25

Beat

by $0.02

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.02

Q2'24

Est.

$-0.11

The last earnings report on May 19 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 3.98K shares outstanding, the current market capitalization sits at 260.03M.

View a ticker or compare two or three

Compare

DRTS